SENSEI BIOTHERAPEUTICS INC

Historical 13F Holders

Symbol
FTH
CUSIP
81728A207
All holders as of
Q2 2026
Type
Equity
Class
COM NEW
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 81728A207 since 12/18/2024, largest first.

Filer % of Class Filed
Khosla Ventures VI, L.P. 13G
10.2% 8/14/2026
Event 6/15/2026
S2G Investments, LLC 13G 10.0% 6/23/2026
Event 6/15/2026
Suvretta Capital Management, LLC 13G
7.8% 6/23/2026
Event 6/15/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (4)
Millennium Management LLC 13G/A
3.1% 6/3/2026
Event 6/1/2026
Caligan Partners LP 13G/A
2.4% 8/14/2026
Event 6/30/2026
Trails Edge Capital Partners, LP 13G/A
2.0% 8/14/2026
Event 6/30/2026
StemPoint Capital LP 13G/A
0% 8/14/2026
Event 6/30/2026

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q2 45 14.1 M $334 M
2026 Q1 31 2.29 M $72.2 M
2025 Q4 10 48.2 k $515 k
2025 Q3 10 49.4 k $467 k
2025 Q2 11 69.9 k $600 k
2025 Q1 1 16.5 k $6.51 k